.@AtlasClearATCH $ATCH Announces $20,000,000 Financing https://t.co/Ak09bO987I

.@skyxplatforms $SKYX Provides Corporate Update Including an Additional $3.25 Million Investment from Leading Investor and Continued Expansion in Builder Segments https://t.co/OtXcVXK3jG

.@AtlasClearATCH $ATCH Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results and Corporate Update https://t.co/u44iiWO5QN

Opus Genetics $IRD Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5) https://t.co/5YBmhgpaxN

We’re excited to partner with AtlasClear Holdings $ATCH to enhance investor relations, digital communications, and market visibility. Together, we look forward to amplifying AtlasClear’s story as it scales its next-generation financial services platform. .@AtlasClearATCH $ATCH

.@AtlasClearATCH $ATCH Secures Additional $2,000,000 Led by 2 Board Members, Completing Previously Announced $5 Million in Funding https://t.co/456Wgbq6Gf

Insight Molecular Diagnostics $IMDX to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando https://t.co/ysNr3gvvcp

.@CoyaTx $COYA Launches the ALSTARS Trial, a Phase 2 Clinical Study to Assess the Efficacy and Safety of COYA 302 in Amyotrophic Lateral Sclerosis https://t.co/2Jqwrd3H6z

.@AtlasClearCoin $ATCH Secures $3,000,000 Financing https://t.co/po4yE7Togk

.@EDGM_Data $EDGM has announced it has entered into an agreement with Blackberry AIF (BAIF) to acquire a portfolio of data center development assets in Spain. https://t.co/dFZCr7v3Rx

.@CoyaTx s' $COYA COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model https://t.co/ReAOCEi7mD

.@CatheterInc $VTAK Announces Tender Win and First Purchase Order in Croatia https://t.co/HHwP3J3sT2

.@QuoinPharma $QNRX has released its fifth episode in its  https://t.co/RkSgdh3cOA  video series. This installment features twin sisters Allie and Kaleigh Fasanella, both living with Netherton Syndrome, as they candidly share their lifelong struggles of managing this devastating

.@CoyaTx Therapeutics' $COYA COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated Trial https://t.co/p8ZxV92OKw

.@CatheterInc Precision $VTAK Announces Introduction of the LockeT Product Line into Italy https://t.co/jqMpDNqyO2

.@EDGM_Data $EDGM is pleased to announce that it has entered into a Memorandum of Understanding (MoU) with Marviken ONE AB. This collaboration underscores EdgeMode’s commitment to sustainable and resilient data center growth while supporting energy innovation in Sweden.

MetaVia $MTVA to Present at Upcoming Investor and Industry Conferences https://t.co/dSQjJ5K6no